A critically ill patient with septicemic plague and peripheral gangrene was treated successfully with ciprofloxacin. There are no previous reports of plague being successfully treated with ciprofloxacin. Peripheral gangrene of this patient's feet was managed with use of sympathetic blockade; the patient's toes appear to have been saved by this approach.
A critically ill patient with septicemic plague and peripheral gangrene was treated successfully with ciprofloxacin. There are no previous reports of plague being successfully treated with ciprofloxacin. Peripheral gangrene of this patient's feet was managed with use of sympathetic blockade; the patient's toes appear to have been saved by this approach.
Yersinia pestis causes plague, which is frequently fatal if appropriate antibiotic therapy is not instituted early in its course [1] . We describe a patient who had septicemic plague with several unique features. The patient was critically ill, was treated successfully with ciprofloxacin, and survived. The infection was complicated by gangrene of the fingers, toes, ears, and nose. Before complete gangrenous demarcation of the lower extremities occurred, we used continuous lumbar epidural regional sympathetic blockade in an attempt to improve blood supply to the feet. We believe this approach resulted in salvage of the patient's toes.
Case report. A 45-year-old, previously healthy white man presented in July 1991 with a 2-day history of increasing fever, myalgia, rigors, headache, and weakness. The patient had a history of camping and sleeping on the ground in an area of northern Arizona where plague was known to be endemic. The patient had no history of rodent exposure or receipt of insect bites.
Physical examination revealed an acutely ill man with a blood pressure of 85/57 mm Hg, a respiratory rate of 26 breaths/min, a heart rate of 117 beats/min, and a temperature of 38.5ЊC. He had acrocyanosis, severe muscle pain, and a purpuric rash with evolving gangrene of the extremities (figure 1). Skin lesions, lymphadenopathy, and pneumonia were not present. His abdomen was diffusely tender, without peritoneal signs. In the ensuing days, he had progressive gangrene of the fingers, toes, ears, and nose.
There was laboratory evidence of disseminated intravascular coagulopathy, renal failure, and metabolic acidosis, all of which were treated conventionally. Blood culture results were negative. However, gram-negative rods were identified within leukocytes on a Gram stain of his peripheral blood smear. Smears of the patient's peripheral blood sample were sent promptly to the Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (Fort Collins, CO), where direct fluorescent antibody stains of the organism were found to be positive for Y. pestis. This finding was subsequently confirmed by seroconversion to Y. pestis, which was determined by passive hemagglutination testing of acute-phase and convalescentphase serum samples: the titers increased from zero to 1:1024.
The patient was treated empirically with ciprofloxacin (300 mg iv b.i.d. for 9 days, followed by 500 mg po b.i.d. for an additional 6 days). The patient's condition gradually improved with ciprofloxacin and supportive care. The gangrene of his hands and feet evolved during the early phase of hospitalization. On the fourth day of hospitalization, a lumbar epidural infusion catheter was placed. An 18-gauge Touhy needle was used, and a styletted 22-gauge epidural catheter was advanced into the epidural space through the needle. A 1.5-mL test dose of lidocaine (1.5%) with 1:200,000 epinephrine was injected to verify that the catheter had not been placed in the subarachnoid space or in a blood vessel. Bupivcaine (0.1%) was slowly infused to allow a gradual onset of sympathetic blockade with minimal hemodynamic change or motor blockade. This was associated with flushing of the lower extremities and increased warmth consistent with increased blood flow to this region. The catheter was left in place for 4 days before removal.
Discussion. Cases of overwhelming sepsis and gangrene are uncommon, but they are seen occasionally in most infectious diseases practices. Besides plague, there are few other infections for which this presentation occurs with increased frequency, such as meningococcemia [2] and, in asplenic patients, pneumococcal or Haemophilus septicemia [3, 4] . In cases of the latter condition, the lack of a spleen predisposes to bacteremia with a large number of organisms that seem to be important in the development of gangrene. Unlike most enteric gram-negative rod septicemia, Y. pestis can occasionally be visualized on the peripheral blood smears of patients with plague [5] . It is likely that, in patients with plague, the bacteremia is associated with a very high number of circulating organisms. It is estimated that 110 6 organisms/mL of blood are necessary before intraleukocytic bacteria can be observed on a peripheral blood smear [1, 4] . Because organisms were observed on the peripheral smear of our patient, we suspected plague and sent the peripheral smear that contained organisms for direct fluorescent antibody testing for Y. pestis. This proved to be a rapid and specific approach to the diagnosis of Y. pestis infection in our patient, because his blood culture results were inexplicably negative.
Early recognition of this condition and prompt initiation of appropriate antibiotic therapy are essential for the successful treatment of septicemic plague, a disease that has a mortality rate of у38% [6] . Often, plague can be fatal before Y. pestis is identified, and virtually 100% of cases of septicemic plague are fatal if untreated [6] . Therefore, it is important to know which antibiotics are effective for treatment of this infection. There is a report of a 31-year-old man with pneumonic plague who was given intramuscular lincomycin and also received ciprofloxacin, which was to be taken orally the next day [7] . The patient died р48 h after he started therapy. We are unaware of any reported cases of plague being treated successfully with ciprofloxacin. Ciprofloxacin was the first broad-spectrum, injectable fluoroquinolone antimicrobial available in the United States. The efficacy of prophylactic and therapeutic ciprofloxacin and doxycycline was studied in mice with severe systemic Y. pestis infection [8] . Ciprofloxacin was found to be highly effective, whereas the performance of doxycycline was poor. In view of its activity against Y. pestis infection in experimental animals, its ability to penetrate leukocytes, and its antimicrobial spectrum, it is reasonable to believe that ciprofloxacin would be effective treatment for plague.
Because plague is an uncommon disease, controlled antibiotic studies are not likely to be performed. Data on the antibiotics that are considered to be effective against this infection have evolved through anecdotal observations and clinical use. Streptomycin is recommended as the drug of choice for treatment of plague, but this drug can be difficult to obtain. Penicillins and cephalosporins have not proven to be consistently effective for plague and are not recommended [6] . Confirmation of plague in our patient did not occur until his condition was improving. Because his condition was improving, no change in antibiotic therapy was made. His improvement and recovery suggest that ciprofloxacin and the supportive care measures used were effective in reversing his severe illness. We observed no adverse reactions to ciprofloxacin.
Our patient had the septicemic form of plague. He had neither a bubo to suggest bubonic plague nor pneumonia to suggest the pneumonic form. Early septicemic plague is difficult to distinguish from septicemia associated with other gramnegative rod infections. However, peripheral gangrene, as was noted in our patient, is more likely to be associated with plague and should be considered suggestive of septicemia due to Y. pestis. The gangrene seen in patients with plague is probably related to physiological changes due to the rapid and high levels of bacteremia generated during this infection. An intense vasoconstriction is presumed to be the basis for the gangrene, and sympathetic nerve blockade has been used in similar situations to reverse peripheral gangrene [2, 3] . We placed a lumbar epidural catheter in our patient for continuous sympathetic blockade, hoping to increase blood flow by vasodilation of the blood vessels to his lower extremities. This was done when the coagulopathy was controlled and the blood pressure was normal. The response to the lumbar blockade was dramatic, and we believe that this was because we were dealing with the blood vessels of a relatively young and previously healthy adult whose health was not compromised by diabetes or peripheral vascular disease. We did not perform specific measurements of bloodflow changes to the patient's lower extremities, but the changes were readily apparent by direct visualization. We think the timely use of this technique improved the chances of reversing the gangrene produced by septicemia. If the gangrene had been allowed to demarcate, it is unlikely that much could have been done to reverse the damage. Our patient's gangrene had not completely demarcated when the sympathetic blockade was attempted. Initially, there was patchy improvement, followed by almost complete resolution of the gangrene on his feet. In contrast, our patient had almost complete necrosis of the tip of his nose, destruction of nasal structures, and sustained loss of fingers due to gangrene. Sympathetic blockade was only used for his lower extremities; damage to areas other than his feet was treated with plastic surgery reconstruction. In the circumstance of evolving gangrene, in a patient with good peripheral blood supply and no bleeding diathesis, sympathetic blockade to preserve tissues might be worth attempting until the primary underlying process has been reversed.
